Labshake search
Citations for R&D Systems :
1 - 50 of 3694 citations for Ethyl 2 pyrrolidin 2 yl 2 3 dihydro 1 3 thiazole 4 carboxylate hydrochloride since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Neuroscience 2024Quote: ... cultures were cotreated with 20 nM (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide dihydrochloride (LM11a-31)(R&D Systems, Minneapolis, MN, USA, Cat no: 5046) or vehicle solution consisting of DMSO during application of 6-OHDA ...
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Immunology 2024Quote: ... from 2-3 donors towards CXCL2 (R&D Systems, cat. 276-GB-010) and RARRES2 (R&D Systems ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Cancer Biology 2023Quote: The blots were probed overnight at 4°C with monoclonal mouse anti-β-Catenin (2 µg/mL in Bovine Serum Albumin 3%, R&D Systems, Minneapolis, USA, #MAB1329), monoclonal rabbit anti-NDRG4 (1:1000 ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 % P/S and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems). Passage 3 hMSCs were used in this study.
-
bioRxiv - Bioengineering 2024Quote: ... type 2 (BME-2; R&D Systems; 3532-010-02), and dispensed in a 24-well plate to form 50 µL BME-2 domes for culture ...
-
bioRxiv - Immunology 2023Quote: ... and 50 U/mL Interleukin-2 (IL-2, R&D Systems). Pre-isolated NK cells were thawed and co-cultured at a 1:1 effector:target (E:T ...
-
bioRxiv - Cell Biology 2022Quote: ... Type 2 (BME-2) droplets (R&D Systems, Minneapolis, MN, USA) and covered under medium ...
-
bioRxiv - Developmental Biology 2020Quote: ... and the combination treatment of Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3). At Day2 ...
-
bioRxiv - Microbiology 2021Quote: ... DY210) were quantified in the supernatants from uninfected and SARS-CoV-2-infected Calu-3 cells by ELISA (R&D Systems), following manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... 2 ng/ mL IGF-1 (R&D Systems), and 10 ng/ mL HGF (R&D Systems) ...
-
bioRxiv - Physiology 2024Quote: ... Contactin-2 1:1000 (R&D Systems AF4439), MLC2v 1:2000 (Proteintech 10906-1-AP) ...
-
bioRxiv - Immunology 2022Quote: IL-4 complexes were generated by incubating 2 μg mouse rIL-4 (R&D Systems) with 10 μg LEAF purified anti-mouse IL4 antibody (clone 11B11 ...
-
bioRxiv - Immunology 2024Quote: ... anti- IL-4 and 2 ng/ml rhTGF-β1 (R&D Systems).
-
bioRxiv - Immunology 2020Quote: T or B cells (2-4 × 107) obtained from 2 spleens of actin-GFP mice by negative MACS kits (Thermo Fisher Scientific, 114.13D; R&D Systems, MAGM204) were intravenously injected to an actin-DsRed mouse ...
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Immunology 2024Quote: ... CXCL-2 (Mouse CXCL2/MIP-2 DuoSet ELISA, DY452, R&D Systems), myeloperoxidase (MPO ...
-
bioRxiv - Microbiology 2021Quote: ... TNF-α and MIF were quantified in the supernatants from uninfected and SARS-CoV-2-infected Calu-3 cells and monocytes by ELISA (R&D Systems), following manufacturer’s instructions ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy individuals were isolated and expanded in vitro for 7 days in the presence of 50 ng/ml of OKT-3 (Miltenyi) and 600 IU/ml IL-2 (R&D Systems) in AIM-V (Gibco ...
-
bioRxiv - Pathology 2020Quote: ... was measured immediately before injection and at 3 days after injection using a Mouse Lipocalin-2/NGAL Quantikine enzyme-linked immunosorbent assay (ELISA) Kit (R&D Systems) to ensure successful injection of folic acid ...
-
bioRxiv - Immunology 2023Quote: ... was pre-incubated with either 10 µl biotinylated SARS-CoV-2 spike protein (3 nM final concentration; R&D Systems cat# BT10549), or with 10 µl biotinylated irrelevant antigen (3 nM final concentration ...
-
bioRxiv - Cell Biology 2024Quote: ... the cells were diluted 1:10 in interleukin 2 (IL-2)-containing RPMI (100 IU/mL; R&D Systems) supplemented with 10 % FBS and penicillin–streptomycin (RPMI-IL-2 ...
-
bioRxiv - Physiology 2020Quote: ... or Contactin 2 (1:1000, R&D Systems, AF4439). Membranes were incubated with secondary antibody Goat anti-rabbit IgG-HRP (1:1000 ...
-
bioRxiv - Physiology 2022Quote: ... Dectin-2 (1:100, clone 17611; R&D Systems), TLR2 (1:200 ...
-
bioRxiv - Cell Biology 2020Quote: ... and the mouse chemoattractant macrophage-inflammatory protein-2 (MIP-2, R&D Systems). Migration of cells was evaluated by trypan blue exclusion following incubation.
-
bioRxiv - Cancer Biology 2022Quote: ... 2 μg/mL Fibulin-2 (Cat no. 9559-FB-050, R&D Systems) coated ...
-
bioRxiv - Cell Biology 2024Quote: ... coated O/N at 4°C with 2% BME® (R&D systems) or 5 µg/ml recombinant Invasin protein ...
-
bioRxiv - Microbiology 2021Quote: Human IL-29/IL-28B (IFN-lambda 1/3) concentration in SARS-CoV-2 infected epithelium basal media was quantified using ELISA technics following manufacturer’s recommendations (R&D systems, Minneapolis, USA). 100 μl of media was used for each point.
-
bioRxiv - Systems Biology 2020Quote: ... Primary detection of hACE-2 was done using a goat anti-hACE-2 antibody (1:1,250; #AF933, R&D Systems), a horseradish peroxidase (HRP)-labeled donkey anti-goat antibody (1:5,000 ...
-
bioRxiv - Physiology 2024Quote: ... The primary antibodies were MyBP-HL [2] and Contactin-2 (R&D Systems AF4439). Secondaries were Alexa Fluor Donkey anti-Rabbit 568 (Thermo Fisher A-10042 ...
-
bioRxiv - Immunology 2021Quote: ... PIGF-2 (R&D systems) and Endoglin/CD105 (R&D systems ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2-APB (R&D Systems), SKF96365 (Wako) ...
-
bioRxiv - Cancer Biology 2023Quote: ... Type 2 (R&D Systems) and plated on 8-chamber slides (Thermo Scientific).
-
bioRxiv - Immunology 2022Quote: ... Lipocalin-2 (R&D Systems) and high sensitivity TNF (Invitrogen ...
-
bioRxiv - Immunology 2024Quote: ... Type 2 (R&D Systems). 37.5μL of matrix was pipetted in the center of each well of an 8-chamber slide (Thermo Scientific ...
-
bioRxiv - Biochemistry 2022Quote: ... 2 µg of recombinant Mac-1 integrin (R&D systems) was incubated with reduced PDI or enzymatically inactive PDI at 10 µM for 30 min at 25°C ...
-
bioRxiv - Immunology 2022Quote: ... Lcn-2 levels were measured using Duoset murine Lcn-2 ELISA Kit (R&D systems) according to the manufacturer’s instructions and results were expressed as pg/g of colon content.
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 1 ng/mL transforming growth factor beta-1 (TGF-β1) and 5 ng/mL fibroblast growth factor-2 (FGF-2) (both from R&D Systems) at 37°C and 5% CO2 in a humidified incubator (Thermo Scientific Heraeus ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 24 and 48 hours intervals from 3 BALB/C mice carrying RCC tumours receiving 1×107 PODS-IL-2 treatment following the final dose and tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Microbiology 2024Quote: ... or N protein of SARS-CoV-2 (dilution 1:2000) or SARS-CoV-2 membrane ab (R&D Systems, Cat no. MAB10690). Followed 3 time washing with PBST (PBS with 0.1 tween 20 ...
-
bioRxiv - Immunology 2021Quote: ... mice were injected subcutaneously with IL-4 complex (IL-4c) comprised of rmIL-4 (2 μg, R&D systems) combined with anti-IL-4 antibody 10 μg ...
-
bioRxiv - Immunology 2021Quote: ... Mouse IL-2 DuoSet ELISA DuoSet and Ancillary Reagent Kit 2 were from R&D Systems.
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...